Lovell JF, Baik Y O, Choi S K, Lee C K, Lee J-Y, Miura K, Huang W-C, Park Y-S, Woo S-J, Seo S H, Kim J-O, Song M, Kim C-J, Choi J-K, Kim J, Choo E J, Choi J-H
Numerous vaccine strategies are being advanced to control SARS-CoV-2, the cause of the COVID-19 pandemic. EuCorVac-19 (ECV19) is a recombinant protein nanoparticle vaccine that displays the SARS-CoV-2 receptor-binding domain (RBD) on immunogenic nanoliposomes.